CoChat

Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival

Assmus, Birgit, Leistner, David M., Schächinger, Volker, Erbs, Sandra, Elsässer, Albrecht, Haberbosch, Werner, Hambrecht, Rainer, Sedding, Daniel, Yu, Jiangtao, Corti, Roberto, Mathey, Detlef G., Barth, Christine, Mayer-Wehrstein, Charlotte, Burck, Iris, Sueselbeck, Tim, Dill, Thorsten, Hamm, Christian W., Tonn, Torsten, Dimmeler, Stefanie, Zeiher, Andreas M., for the REPAIR-AMI Study Group, Estel, Stephanie, Braun, Heike, Geweyer, Isabell, Palapies, Lars · 2014 · European Heart Journal
Cited by 116

The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.

Abstract

BACKGROUND: In the REPAIR-AMI trial, intracoronary infusion of bone marrow-derived cells (BMCs) was associated with a significantly greater recovery of contractile function in patients with acute myocardial infarction (AMI) at 4-month follow-up than placebo infusion. The current analysis investigates clinical outcome and predictors of event-free survival at 5 years. METHODS AND RESULTS: In the multicentre, placebo-controlled, double-blind REPAIR-AMI trial, 204 patients received intracoronary infusion of BMCs (n = 101) or placebo (n = 103) into the infarct vessel 3-7 days following successful percutaneous coronary intervention. Fifteen patients died in the placebo group compared with seven patients in the BMC group (P = 0.08). Nine placebo-treated patients and five BMC-treated patients required rehospitalization for chronic heart failure (P = 0.23). The combined endpoint cardiac/cardiovascular/unknown death or rehospitalisation for heart failure was more frequent in the placebo compared with the BMC group (18 vs. 10 events; P = 0.10). Univariate predictors of adverse outcomes were age, the CADILLAC risk score, aldosterone antagonist and diuretic treatment, changes in left ventricular ejection fraction, left ventricular end-systolic volume, and N-terminal pro-Brain Natriuretic Peptide (all P < 0.01) at 4 months in the entire cohort and in the placebo group. In contrast, in the BMC group, only the basal (P = 0.02) and the stromal cell-derived factor-1-induced (P = 0.05) migratory capacity of the administered BMC were associated with improved clinical outcome. CONCLUSION: In patients of the REPAIR-AMI trial, established clinical parameters are associated with adverse outcome at 5 years exclusively in the placebo group, whereas the migratory capacity of the administered BMC determines event-free survival in the BMC-treated patients. These data disclose a potency-effect relationship between cell therapy and long-term outcome in patients with AMI.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1093/eurheartj/ehu062

Cites

3 of 3 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 3 references

Cited by

See all 116

Metadata

Authors
Assmus, B., Leistner, D. M., Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Sedding, D., Yu, J., Corti, R., Mathey, D. G., Barth, C., Mayer-Wehrstein, C., Burck, I., Sueselbeck, T., Dill, T., Hamm, C. W., Tonn, T., Dimmeler, S., Zeiher, A. M., for the REPAIR-AMI Study Group, Estel, S., Braun, H., Geweyer, I., & Palapies, L.
Venue
European Heart Journal
Published
2014-02-25
Volume
35
Issue
19
Pages
1275-1283
ISSN
  • 0195-668X (ISSN-L)
  • 1522-9645
OpenAlex
W2155533706
Cited by
116
References
3
FWCI
10.35
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. https://app.cochat.ai/papers/10.1093/eurheartj/ehu062
The paper
Assmus, B., Leistner, D. M., Schächinger, V., Erbs, S., Elsässer, A., Haberbosch, W., Hambrecht, R., Sedding, D., Yu, J., Corti, R., Mathey, D. G., Barth, C., Mayer-Wehrstein, C., Burck, I., Sueselbeck, T., Dill, T., Hamm, C. W., Tonn, T., Dimmeler, S., . . . Palapies, L. (2014). Long-term clinical outcome after intracoronary application of bone marrow-derived mononuclear cells for acute myocardial infarction: migratory capacity of administered cells determines event-free survival. European Heart Journal. https://doi.org/10.1093/eurheartj/ehu062

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.